Breandán N Kennedy Selected Research

Vision Disorders (Hemeralopia)

1/2010

Photoreceptor guanylate cyclases and cGMP phosphodiesterases in zebrafish.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Breandán N Kennedy Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 04/2009
5	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 04/2009
5	Blindness (Hysterical Blindness) 01/2020 - 02/2003
5	Retinal Degeneration 01/2020 - 01/2016
3	Adenocarcinoma 01/2020 - 02/2019
3	Eye Diseases (Eye Disease) 11/2016 - 11/2009
2	Uveal melanoma 02/2022 - 10/2020
2	Retinal Diseases 10/2017 - 01/2010
2	Microphthalmos 09/2014 - 06/2004
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Hemangioblastoma 01/2020
1	Macular Degeneration (Age-Related Maculopathy) 01/2020
1	Psoriatic Arthritis 09/2019
1	Inflammation (Inflammations) 09/2018
1	Hypopigmentation (Hypomelanosis) 12/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Cone-Rod Dystrophies 12/2016
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 12/2016
1	Infections 10/2016
1	Retinal Neovascularization 04/2016
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2016
1	Anophthalmos (Anophthalmia) 09/2014
1	Toxic Optic Neuropathy 01/2014
1	Poisoning 11/2011
1	Ganglion Cysts (Ganglion) 04/2011
1	Vision Disorders (Hemeralopia) 01/2010
1	Disease Progression 04/2009
1	Photophobia (Light Sensitivity) 09/2008
1	Achromatopsia 2 04/2008
1	Color Vision Defects (Color Blindness) 02/2007

Drug/Important Bio-Agent (IBA)

11	Retinaldehyde (Retinal)IBA 01/2020 - 02/2003
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2008
4	Pharmaceutical PreparationsIBA 10/2020 - 04/2009
3	Histone Deacetylase InhibitorsIBA 02/2022 - 01/2016
3	quininibIBA 10/2020 - 10/2016
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 12/2017
2	Bevacizumab (Avastin)FDA Link 10/2020 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 10/2016
1	ricolinostatIBA 02/2022
1	Microphthalmia-Associated Transcription FactorIBA 02/2022
1	ProteomeIBA 02/2022
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2020
1	AS 8IBA 10/2020
1	Conditioned Culture MediaIBA 10/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Histone Deacetylase 6IBA 01/2020
1	Phenol (Carbolic Acid)FDA Link 10/2019
1	PyrazinesIBA 10/2019
1	MicroRNAs (MicroRNA)IBA 09/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 06/2019
1	Cisplatin (Platino)FDA LinkGeneric 02/2019
1	CytokinesIBA 09/2018
1	AdipokinesIBA 09/2018
1	Coloring Agents (Dyes)IBA 12/2017
1	tubastatin AIBA 01/2017
1	PeroxiredoxinsIBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Dyneins (Dynein)IBA 12/2016
1	Monomeric GTP-Binding ProteinsIBA 12/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	cysteinyl-leukotrieneIBA 01/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2016
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	RetinoidsIBA 09/2014
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2009
1	Retinal Pigments (Pigments, Visual)IBA 09/2008
1	OpsinsIBA 09/2008
1	TransducinIBA 02/2007
1	MorpholinosIBA 06/2004
1	Carrier Proteins (Binding Protein)IBA 02/2003

Therapy/Procedure

1	Neoadjuvant Therapy 01/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 10/2017
1	Intraocular Injections 10/2016